Teleflex Incorporated $TFX Position Trimmed by Invesco Ltd.

Key Points

• Invesco Ltd. has reduced its holdings in Teleflex by 87.5%, selling 934,736 shares, leaving them with 133,857 shares valued at approximately $18.5 million.
• Teleflex reported a quarterly earnings per share (EPS) of $3.73, exceeding analyst expectations of $3.36, with revenue of $780.9 million for the quarter.
• The company announced a quarterly dividend of $0.34 per share, representing an annual yield of 1.1%, with the ex-dividend date set for August 15th.

Invesco Ltd. reduced its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 87.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 133,857 shares of the medical technology company's stock after selling 934,736 shares during the period. Invesco Ltd. owned 0.30% of Teleflex worth $18,498,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Covestor Ltd raised its holdings in Teleflex by 64.9% during the first quarter. Covestor Ltd now owns 480 shares of the medical technology company's stock worth $66,000 after acquiring an additional 189 shares in the last quarter. Maryland State Retirement & Pension System grew its stake in shares of Teleflex by 485.5% in the 1st quarter. Maryland State Retirement & Pension System now owns 15,739 shares of the medical technology company's stock valued at $2,175,000 after buying an additional 13,051 shares during the period. ASR Vermogensbeheer N.V. acquired a new position in Teleflex during the 1st quarter valued at about $223,000. Corbyn Investment Management Inc. MD lifted its position in shares of Teleflex by 2.4% during the 1st quarter. Corbyn Investment Management Inc. MD now owns 19,764 shares of the medical technology company's stock worth $2,731,000 after buying an additional 460 shares in the last quarter. Finally, Costello Asset Management INC bought a new position in shares of Teleflex during the 1st quarter worth approximately $28,000. Institutional investors own 95.62% of the company's stock.

Insiders Place Their Bets

In other news, Director Jaewon Ryu bought 1,500 shares of Teleflex stock in a transaction on Tuesday, August 5th. The shares were bought at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the acquisition, the director owned 3,727 shares in the company, valued at approximately $428,605. This trade represents a 67.36% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Andrew A. Krakauer bought 1,000 shares of Teleflex stock in a transaction on Tuesday, August 5th. The stock was purchased at an average price of $115.25 per share, for a total transaction of $115,250.00. Following the completion of the acquisition, the director owned 7,192 shares in the company, valued at $828,878. This represents a 16.15% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 5,500 shares of company stock worth $633,590. Corporate insiders own 1.40% of the company's stock.

Teleflex Stock Up 0.4%

TFX stock traded up $0.50 during midday trading on Tuesday, reaching $128.05. 198,832 shares of the company were exchanged, compared to its average volume of 785,841. The company has a market cap of $5.66 billion, a price-to-earnings ratio of 30.07, a price-to-earnings-growth ratio of 1.80 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90. The stock's 50-day simple moving average is $118.28 and its 200 day simple moving average is $130.03.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.36 by $0.37. The business had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's payout ratio is presently 32.00%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Royal Bank Of Canada boosted their price target on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. Mizuho boosted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research note on Friday, August 1st. Wells Fargo & Company dropped their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Wall Street Zen raised shares of Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Finally, Morgan Stanley dropped their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. One investment analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Teleflex has a consensus rating of "Hold" and a consensus target price of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.